Joseph Saldanha
Keine laufenden Positionen mehr
Profil
Joseph Saldanha served as Vice President-Marketing & Business Development at MannKind Corp.
from 2016 to 2017.
He then worked as Chief Business Officer at Valeritas Holdings, Inc. from 2018 to 2020.
Prior to that, he was the General Manager-Julphar Diabetes Division at Gulf Pharmaceutical Industries from 2012 to 2015.
Saldanha holds a graduate degree from the University of Pennsylvania and an undergraduate degree from Drexel University.
Ehemalige bekannte Positionen von Joseph Saldanha
| Unternehmen | Position | Ende |
|---|---|---|
| VALERITAS HOLDINGS, INC. | Corporate Officer/Principal | 06.03.2020 |
| MANNKIND CORPORATION | Vertrieb & Marketing | 01.07.2017 |
| GULF PHARMACEUTICAL INDUSTRIES | Corporate Officer/Principal | 01.05.2015 |
Ausbildung von Joseph Saldanha
| Drexel University | Undergraduate Degree |
| University of Pennsylvania | Graduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 2 |
|---|---|
| GULF PHARMACEUTICAL INDUSTRIES | Health Technology |
| MANNKIND CORPORATION | Health Technology |
| Private Unternehmen | 1 |
|---|---|
Valeritas Holdings, Inc.
 Valeritas Holdings, Inc. Medical SpecialtiesHealth Technology Valeritas Holdings, Inc. develops and commercializes insulin delivery devices. The company was founded by Leisa Swanson and Robert R. Gonnelli on August 2, 2006 and is headquartered in Bridgewater, NJ. | Health Technology |